MedTrace Logo

Ascending Glycan Dietary Supplementation in Healthy Adults

NCT04466761 · Status: TERMINATED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2024-11-12

No results posted yet for this study

Summary

The investigators will conduct a parallel-group, placebo-controlled, randomized, double-blind ascending dose Phase I study of dietary supplementation in healthy individuals to evaluate safety and to determine the pharmacologically effective dose (ED).

Conditions

  • Healthy Individuals

Interventions

DIETARY_SUPPLEMENT

Monosaccharide Powder

Monosaccharide powder dissolved in water.

OTHER

Placebo Comparator

Placebo (cellulose powder).

Sponsors & Collaborators

  • University of California, Davis

    lead OTHER

Principal Investigators

  • Emanual Maverakis, MD · University of California, Davis

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-06-23
Primary Completion
2024-08-06
Completion
2024-08-06

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04466761 on ClinicalTrials.gov